<ul data-eligibleForWebStory="false"><li>Mendaera Inc. has received FDA clearance for its Focalist handheld robotic system designed to simplify and enhance precision of ultrasound-guided needle placement.</li><li>The company aims to make precision surgery more accessible across healthcare with a focus on providing tools to support precise and consistent needle placement across various users and clinical settings.</li><li>The Focalist system integrates handheld control, real-time ultrasound imaging, and advanced software, allowing for reproducible minimally invasive procedures.</li><li>Mendaera is commencing a limited launch of the Focalist system in select medical institutions and plans for full commercialization by 2026, starting with applications in urology.</li></ul>

Mendaera earns FDA clearance for Focalist handheld robotic system

Discover more